🇮🇳 India Stock Screener ← Switch market ★ Elite Club ⚡ HerAI

Sigachi Industries Limited SIGACHI NSEPHARMA

Healthcare · Drug Manufacturers - Specialty & Generic · India
https://sigachi.com
Company Profile ↓
₹25.50
-38.35% 1Y
Mkt Cap₹974.40 Cr
P/E12.38
P/B1.71
Div. Yield0.44%
52W High₹44.38
52W Low₹16.92
Book Value₹13.65
EPS (TTM)₹2.06

Company Overview

Sigachi Industries Limited manufactures and sells microcrystalline cellulose and cellulose powder in India. The company offers cellulose-based products under the HiCel, AceCel, CoatCel, GloCel, and BARETab names; and various chemicals, including colloidal silicon dioxide, carboxy cellulose sodium and mannitol, etc. to active pharmaceutical ingredients, food and nutrition, cosmetic, and chemical industries. It also provides operations and maintenance services in the fields of speciality chemicals, petrochemicals, water treatment, and pharmaceuticals. In addition, the company exports its products. Sigachi Industries Limited was incorporated in 1989 and is headquartered in Hyderabad, India.

Why Investors Should Care

Steady Revenue Expansion

Revenue has grown at a 16.5% CAGR over the past five years.

Reasonable Valuation

Trades at a P/E of 12.4, below the sector median of 38.5.

Conservative Balance Sheet

Carries low leverage with a debt-to-equity ratio of 0.31.

Recent Developments

  • Mar 2026 Revenue of ₹477.83 Cr (-2.1% YoY); net profit ₹-81.76 Cr.
  • Trailing 12 Months Year-on-year growth — revenue -2.1%, earnings -217.5%.
  • 5-Year Trend Long-term compounding — revenue CAGR 16.5%, profit CAGR -95.9%.

Growth & Price Performance

Compounded Sales Growth

5 Years:16.52%
1 Year:-2.13%

Compounded Profit Growth

5 Years:-95.93%
1 Year:-217.53%

Stock Price Performance

1 Year:-38.35%
6 Months:+5.46%
3 Months:+21.26%
1 Month:+2.82%

Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.

Technical Snapshot Mixed
52-Week Range 31% of range
₹16.92 ₹44.38
Trend Signals
  • Price vs 50-DMAAbove
  • Price vs 200-DMABelow
  • RSI (14)63.39 · Neutral
Price Performance
1M+2.82%
3M+21.26%
6M+5.46%
1Y-38.35%
Valuation vs Sector

P/E of 12.38 is below the sector median of 38.45 — relatively cheaper than peers.

Auto-generated from price history and fundamentals; not investment advice.

⚙Ad space

Price Chart

NSE TradingView

Fundamental Growth Charts

Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.

PROS

  • Compounding revenue at 16.5% over 5 years.

CONS

  • Earnings shrank at -95.9% CAGR over 5 years.
  • Trading 42.5% below its 52-week high.
  • In a downtrend (50-DMA below 200-DMA).

* The pros and cons are auto-generated from financial metrics.

⚙Ad space

Valuation

Stock P/E
12.38
Industry PE
38.45
Forward P/E est.
24.76
PEG Ratio
-
Book Value
₹13.65
Price to Book
1.71
P/S
1.82
EV/EBITDA
16.69
Dividend Yield
0.44%

Growth (CAGR)

Revenue 5Y
16.52%
Profit 5Y
-95.93%
Revenue (YoY)
-2.13%
Earnings (YoY)
-217.53%

Profitability & Returns

ROCE
-12.93%
ROE
-15.67%
ROA
-9.72%
Profit Margin
-17.11%
Op Margin
7.57%
Gross Margin
48.16%
EPS (Latest Qtr)
₹0.20
EPS (TTM)
₹2.06

Balance Sheet & Liquidity

Debt/Equity
0.31
Quick Ratio
1.17
Current Ratio
1.44
Debt
₹162.26 Cr
Total Assets
₹841.17 Cr
Current Assets
₹389.35 Cr
Working Capital
₹118.87 Cr

Ownership

Promoter Holding
41.88%
Chg in Prom Hold
-3.47%
FII / Inst Holding
1.07%
Chg in FII Hold
-0.02%

Financial Snapshot

Enterprise Value
₹974.40 Cr
Total Revenue (TTM)
₹477.83 Cr
EBITDA
₹-56.21 Cr
Free Cash Flow
₹-36.86 Cr
Operating Cash Flow
₹4.30 Cr
Shares Outstanding
₹38.21 Cr
Gross Margin
48.16%
Payout Ratio
4.85%

Peer comparison

Peer companies in the same sector (Healthcare).

#NameCMP ₹P/E Mkt CapDiv Yld % ROCE %ROE % Rev CAGR 5Y %Profit CAGR 5Y %
1 SIGACHI Sigachi Industries Limited NSEPHARMA 25.50 12.38 ₹974.40 Cr 0.44% -12.93% -15.67% 16.52% -95.93%
2 SUNPHARMA Sun Pharmaceutical Industries Limited NIFTY50NSEAIPHARMA 1,941.10 40.61 ₹4.66 L Cr 0.83% 17.94% 13.74% 10.39% 10.65%
3 DIVISLAB Divi's Laboratories Limited NSEPHARMA 7,248.50 74.92 ₹1.92 L Cr 0.44% 18.96% 15.32% 11.27% 12.08%
4 TORNTPHARM Torrent Pharmaceuticals Limited NSEPHARMA 4,961.50 87.86 ₹1.68 L Cr 0.78% 9.05% 25.79% 13.27% 20.22%
5 APOLLOHOSP Apollo Hospitals Enterprise Limited NIFTY50NSEAIPHARMA 8,805.50 65.21 ₹1.27 L Cr 0.23% 19.79% 20.48% 15.33% 33.34%
6 CIPLA Cipla Limited NIFTY50NSEAIPHARMA 1,410.60 21.62 ₹1.14 L Cr 0.90% 14.86% 11.27% 7.23% 11.45%
7 ZYDUSLIFE Zydus Lifesciences Limited NSEPHARMA 1,108.70 22.13 ₹1.12 L Cr 0.09% 19.04% 18.59% 16.55% 36.99%
8 LUPIN Lupin Limited NIFTY_MIDNSEPHARMA 2,370.50 20.36 ₹1.08 L Cr 0.72% 28.42% 23.76% 19.10% 131.46%
9 MAXHEALTH Max Healthcare Institute Limited NSEAIPHARMA 1,080.40 98.13 ₹1.05 L Cr 0.18% 12.57% 13.42% 22.37% 9.34%
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios

Quarterly Results

Figures in INR.

Metric Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Revenue 72.42 Cr84.70 Cr99.18 Cr110.95 Cr104.13 Cr95.71 Cr124.90 Cr139.42 Cr128.20 Cr128.25 Cr110.48 Cr117.21 Cr121.90 Cr
Cost of Revenue -------64.75 Cr50.97 Cr62.80 Cr-65.24 Cr59.37 Cr
Gross Profit -------74.67 Cr77.24 Cr65.45 Cr-51.97 Cr62.52 Cr
Operating Expenses 60.25 Cr68.39 Cr77.76 Cr88.36 Cr87.80 Cr74.69 Cr107.67 Cr46.16 Cr53.43 Cr46.07 Cr102.96 Cr50.43 Cr50.69 Cr
Operating Income 10.19 Cr14.35 Cr18.90 Cr19.77 Cr12.84 Cr17.87 Cr14.01 Cr28.51 Cr23.81 Cr19.38 Cr3.41 Cr1.53 Cr11.84 Cr
EBITDA 12.17 Cr16.31 Cr21.42 Cr22.59 Cr16.33 Cr21.02 Cr17.23 Cr35.19 Cr30.75 Cr-92.96 Cr7.52 Cr5.45 Cr16.62 Cr
Interest Expense 1.41 Cr1.27 Cr1.79 Cr1.84 Cr2.87 Cr3.16 Cr2.10 Cr3.82 Cr3.33 Cr3.31 Cr3.13 Cr3.13 Cr4.33 Cr
Pretax Income 10.33 Cr14.71 Cr18.22 Cr19.64 Cr17.21 Cr16.39 Cr26.55 Cr26.71 Cr22.67 Cr-100.99 Cr7.43 Cr-1.85 Cr7.71 Cr
Tax Provision 3.02 Cr3.83 Cr3.10 Cr3.54 Cr2.04 Cr3.64 Cr5.53 Cr6.19 Cr6.50 Cr-2.21 L-3.09 Cr-1.84 Cr6.48 L
Net Income 7.32 Cr10.88 Cr15.12 Cr16.10 Cr15.17 Cr12.76 Cr21.01 Cr21.35 Cr13.27 Cr-100.35 Cr10.53 Cr19.70 L7.71 Cr
Diluted EPS 0.240.350.490.500.460.400.650.520.39-2.630.280.010.20

Profit & Loss (Annual)

Figures in INR.

Metric Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue 101.00 Cr129.00 Cr139.00 Cr193.00 Cr-302.05 Cr398.96 Cr488.24 Cr477.83 Cr
Cost of Revenue -----162.03 Cr224.64 Cr222.13 Cr247.72 Cr
Gross Profit -----140.02 Cr174.32 Cr266.11 Cr230.11 Cr
Operating Expenses 89.00 Cr103.00 Cr114.00 Cr154.00 Cr-87.42 Cr108.31 Cr181.90 Cr193.94 Cr
Operating Income 11.00 Cr24.00 Cr23.00 Cr37.00 Cr-52.60 Cr66.01 Cr84.21 Cr36.17 Cr
EBITDA 12.00 Cr26.00 Cr25.00 Cr39.00 Cr-64.20 Cr85.83 Cr120.51 Cr-56.21 Cr
Interest Expense 4.00 Cr3.00 Cr2.00 Cr1.00 Cr-3.09 Cr5.26 Cr12.41 Cr13.90 Cr
Pretax Income 10.00 Cr25.00 Cr25.00 Cr38.00 Cr-54.48 Cr69.77 Cr92.32 Cr-87.70 Cr
Tax Provision 2.80 Cr5.75 Cr5.00 Cr7.98 Cr-10.94 Cr12.51 Cr21.86 Cr-4.89 Cr
Net Income 7.00 Cr19.00 Cr20.00 Cr30.00 Cr-43.54 Cr57.18 Cr69.56 Cr-81.76 Cr
Diluted EPS 2.256.192.653.941.541.421.542.06-

Balance Sheet (Annual)

Figures in INR.

Metric Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets 72.00 Cr91.00 Cr109.00 Cr133.00 Cr-373.75 Cr694.16 Cr846.21 Cr841.17 Cr
Current Assets -----177.41 Cr313.26 Cr394.33 Cr389.35 Cr
Cash & Equivalents -----13.75 Cr17.40 Cr17.26 Cr20.90 Cr
Inventory -----46.60 Cr70.72 Cr94.27 Cr73.59 Cr
Receivables -----80.17 Cr150.04 Cr183.67 Cr224.20 Cr
Total Liabilities -----105.39 Cr253.13 Cr233.13 Cr312.29 Cr
Current Liabilities -----74.63 Cr187.82 Cr185.12 Cr270.47 Cr
Long Term Debt -----1.01 Cr26.58 Cr00
Total Debt 30.00 Cr25.00 Cr30.00 Cr21.00 Cr-68.48 Cr151.07 Cr142.31 Cr162.26 Cr
Total Equity 26.00 Cr45.00 Cr65.00 Cr95.00 Cr-268.36 Cr429.64 Cr600.85 Cr521.72 Cr
Shares Outstanding -----30.74 Cr32.82 Cr38.21 Cr38.21 Cr

Cash Flows (Annual)

Figures in INR.

Metric Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow 8.00 Cr14.00 Cr12.00 Cr30.00 Cr-29.02 Cr12.89 Cr26.93 Cr4.30 Cr
Investing Cash Flow -4.00 Cr-6.00 Cr-7.00 Cr-11.00 Cr--91.85 Cr-160.74 Cr-93.07 Cr-52.55 Cr
Financing Cash Flow -5.00 Cr-9.00 Cr3.00 Cr-11.00 Cr-26.21 Cr172.10 Cr81.10 Cr2.24 Cr
Capital Expenditure -5.00 Cr-5.00 Cr-6.00 Cr-10.00 Cr--100.72 Cr-85.19 Cr-43.33 Cr-41.17 Cr
Free Cash Flow 3.00 Cr9.00 Cr6.00 Cr20.00 Cr--71.70 Cr-72.30 Cr-16.40 Cr-36.86 Cr
Net Change in Cash -1.00 Cr-08.00 Cr7.00 Cr--36.63 Cr24.25 Cr14.96 Cr-46.01 Cr

Ratios (Annual)

Figures in %.

Metric Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Gross Margin % -----46.4%43.7%54.5%48.2%
Operating Margin % 10.9%18.6%16.5%19.2%-17.4%16.5%17.2%7.6%
Net Margin % 6.9%14.7%14.4%15.5%-14.4%14.3%14.2%-17.1%
ROE % 26.9%42.2%30.8%31.6%-16.2%13.3%11.6%-15.7%
ROCE % -----17.6%13.0%12.7%6.3%

Shareholding Pattern

Insiders
41.88%
Institutions
1.07%
Public Float
1.84%

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for SIGACHI

Google News Sun, 26 Jul 2026

Sigachi Industries postpones Q1FY27 earnings call due to unavoidable circumstances - scanx.trade

<a href="https://news.google.com/rss/articles/CBMitgFBVV95cUxObHJzRW5hZTh6ZHVEZGhDZXFSVzc3dWRRdUpRVVJYV0xVbURPVktzaXkxVkJ0VEN0WUIzWjNuUWdSYzBMcXhNR3ZOcTJ4aXI3aGFKMkpfV082dDV4Y0w1dkloT1RrdlV0aGFScVc5TFZxUk4xM215eW1FbGZWcnhmQ1k3cmk2WU16MlY4cX…

Google News Wed, 21 Jan 2026

Slammed 29% Sigachi Industries Limited (NSE:SIGACHI) Screens Well Here But There Might Be A Catch - simplywall.st

<a href="https://news.google.com/rss/articles/CBMi8AFBVV95cUxQNUxNaTNqNjJPdTJ4bThBZ2ZUQWxxaFVOa3ZQVGVoYWZhQjdheXUySTc2bjBlLWo4RDNOTVdzbG9HWWVCOEZPZ2ZrSEcxWG1kWVlkdHIwUi1yRnRDNWNUU003U1ZPQ1JlNmpjdjBWYmlsdEd1QWtwY0NvbVBfLVUzYmsxbGlXbGZOVVRNdD…

Google News Wed, 04 Feb 2026

Sigachi Industries shares rally 20% after CEO gets bail in factory blast case - Moneycontrol.com

<a href="https://news.google.com/rss/articles/CBMi2AFBVV95cUxQRnFQbWRaZVV3aUI2T0VmZTl2aWR2NWJEUHdHZVhrZWxaT1BNZGdFTlBJbndmWEJjOFdIUTY3WTM0UFVxcWxMZkJwaFRUZDA1eXdVaThvNENPVDBVYmlsRE5ZanhEZ0hnUXJZQjBuRFRXbThDVVFVZ2QtY3ZKUVhfVlNYUzlmaXJReTJWTG…

Google News hu, 29 Jan 2026

Sigachi Industries - Smallcap bloodbath: 10 stocks tumble up to 40% in first month of 2026. Do you own any? - The Economic Times

<a href="https://news.google.com/rss/articles/CBMigwJBVV95cUxNNzA2M0VpVGNfOWRfXzZCY1hwM0xmdUtjdmpha2UtT0MzYjA0OHloN19xd3VzMVE4b29mbWpPRnpvMW9UTHJjNUJTbWI0NVVDcmhiOElnejRFaVRQbm03Y0JQcnhacFk1Tmt4Vm5OaFNTSER4QWtOemt4TTYxSy1nSWt2NW0zbW5JbjRQRT…

Google News Mon, 29 Dec 2025

Sigachi Industries hits over 2-year low as CEO remand weighs on stock - Business Standard

<a href="https://news.google.com/rss/articles/CBMi0gFBVV95cUxPVUd3ZkJSbXdiM0lzMFMtR0FSb0hBRDlkMWNzemxFLXRPSW9FY2k3SlY0Mk0tbG9RV0tYdUNMTmY2em1CdlpuTEpQTUpzUTlRNndkYmNzNjZsRTNVQ05FWmVhbWFKSndScDNDZVZBRzRqSHRLSnhuZHpMNXdOXzRYSlpaYWFWWElyRmN6Un…

Google News Wed, 21 Jan 2026

Shares of THIS company in focus after it highlights update on advancement in Cystic Fibrosis APIs, details he - India.Com

<a href="https://news.google.com/rss/articles/CBMi_gFBVV95cUxOWTV0T1BqcDVFSG90YkoxN0NtdFlkUnhxcXFTRF90eXJEV0xZalprdzh2VlJhSW8yYUk4NC0tUGxja0lLYWNUQUdPRDVhWHpjbXk3ZERqajRNcWpRczYzZk9DNUQwTG5qMHRoT21IV1doMFNjcmQyNkc3b1BoXzdSMTFkanU5RGxnc2Q3V3…

SIGACHI — Frequently Asked Questions

What is the current share price of Sigachi Industries Limited (SIGACHI)?

As of 2026-07-27 05:56 IST, Sigachi Industries Limited (SIGACHI) trades at ₹25.50 on NSE. Its 52-week range is ₹16.92 to ₹44.38.

What is the market capitalisation of SIGACHI?

Sigachi Industries Limited (SIGACHI) has a market capitalisation of ₹974.40 Cr on NSE.

What is the P/E ratio of SIGACHI?

SIGACHI trades at a trailing price-to-earnings (P/E) ratio of 12.38. The industry average P/E is 38.45. Its price-to-book (P/B) ratio is 1.71.

Does SIGACHI pay a dividend?

Sigachi Industries Limited (SIGACHI) currently offers a dividend yield of 0.44%.

What is the return on equity (ROE) of SIGACHI?

SIGACHI has a return on equity (ROE) of -15.67%. Its return on capital employed (ROCE) is -12.93%.

Is SIGACHI a good stock to buy?

This page provides a data-driven analysis of Sigachi Industries Limited (SIGACHI), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Explore More

📊 Healthcare Sector 🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All India Stocks
⚙Ad space